Adocia Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Adocia

Adocia | Ownership

Companies that own Adocia

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Talence Gestion SAS

45,000

0.65%

0.23%

07/31/2018

Uzes Gestion SA

23,000

0.33%

0.3%

08/31/2018

AcomeA SGR SpA

13,190

0.19%

140

0.06%

10/31/2017

Perinvest (UK) Ltd.

13,000

0.19%

13,000

1.57%

06/30/2017

Bruno Walter Finance SA

10,000

0.14%

0.2%

02/28/2018

CPR Asset Management SA

6,646

0.1%

5,924

12/30/2016

Monega Kapitalanlagegesellschaft mbH

6,150

0.09%

0.02%

07/31/2018

Société Générale Gestion SA

5,516

0.08%

01/31/2018

Deka Investment GmbH

5,500

0.08%

5,500

06/29/2018

Fédéral Finance Gestion SA

5,000

0.07%

10/31/2016

About Adocia

View Profile

Address	115 avenue Lacassagne Lyon Rhone-Alpes 69003 France
Employees	-
Website	http://www.adocia.com
Updated	07/08/2019
Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: BioChaperone Lispro; BioChaperone Combo; HinsBet; BioChaperone Human Glucagon; BioChaperone Glargine GLP-1; and BioChaperone Prandaial Combinations for T1D. The company was founded by Gérard, Olivier, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.